60. Aplastic anemia Clinical trials / Disease details


Clinical trials : 235 Drugs : 381 - (DrugBank : 83) / Drug target genes : 44 - Drug target pathways : 160

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03836690
(ClinicalTrials.gov)
October 21, 201910/1/2019Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationPhase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationLymphoma;Leukemia;Myeloma;Myelodysplastic Syndromes;Severe Aplastic Anemia;Primary Immune Deficiency;Graft Vs Host DiseaseBiological: CD62L- TemUniversity College, LondonMedical Research CouncilRecruiting16 Years70 YearsAll18Phase 1United Kingdom